Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Peficitinib(CAS 944118-01-8) Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Medical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Peficitinib(CAS 944118-01-8) Market by Type (Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%), By Application (Research, Medical) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 450684 4200 Chemical & Material 377 201 Pages 4.9 (37)
                                          

Market Overview:


The global peficitinib market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing R&D expenditure by pharmaceutical companies, and growing demand for targeted therapies. However, the high cost of peficitinib may restrain the growth of this market to some extent. The global peficitinib market is segmented on the basis of type, application, and region. On the basis of type, it is divided into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. By application, it is classified into research and medical segments. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia), and Middle East & Africa (Saudi Arabia UAE Qatar South Africa).


Global Peficitinib(CAS 944118-01-8) Industry Outlook


Product Definition:


Peficitinib is a novel, investigational small molecule JAK1 inhibitor with potential antineoplastic activity.


Min Purity Less Than 98%:


Min Purity Less Than 98% is a special range of chemicals, which contains more than 98% pure substance. It’s used in the production of pefectinib (CAS 944118-01-8). This chemical falls under the category of purine derivatives. Purine derivatives are compounds, which are derived from the breakdown of DNA and RNA. The most common types include xanthine and hypoxanthine.


Min Purity 98%-99%:


Min Purity 98%-99% is a special grade of Purified Water, which means it has passed through several purification processes to achieve the highest level of purity. It contains no additives and is suitable for producing high-purity chemicals.


It can be used in pharmaceuticals, chemical synthesis, food & beverage processing and other industries that require highly pure water or water with low contaminants such as suspended solids & organic compounds.


Application Insights:


Medical application of peicitinib accounted for the largest share of over 70.0% in 2017 owing to its extensive use as a radiosensitizer and radiopharmaceutical carrier in cancer treatment. It is also used as an imaging agent for the detection of breast cancer, lung cancer, and other cancers. The growing adoption of peicitinib radioisotope applications in medical oncology research is expected to drive demand over the forecast period.


The research segment is anticipated to witness significant growth during the study period owing to increasing R&D initiatives by various public and private institutions across the globe for developing new potential usespecifically focusing on solid tumors such as pancreatic, liver & biliary system cancers, melanoma skin tumor, thyroid tumor etc. This factor has ledto increased R&D spending by various market players which will further boost product demand globally during this forecast period.


Regional Analysis:


North America was the largest regional market for peficitinib in 2017. The growth of this region is attributed to the presence of a large number of key pharmaceutical and biopharmaceutical companies, which are engaged in drug development activities. Moreover, rising incidence rates of kidney diseases have led to an increase in demand for proteinuric drugs across this region.


Asia Pacific is expected to be one of the fastest-growing regions during the forecast period owing to factors such as increasing healthcare spending by governments and private sectors coupled with growing awareness about new generation therapeutics among patients & physicians. Furthermore, favorable government initiatives towards improving healthcare infrastructure are anticipated to fuel industry growth over here during the forecast period  (2018 - 2030). For instance, ‘Make in India’ initiative undertaken by Indian government aims at promoting manufacturing output within country resulting into increased production capacity for generic drugs as well as branded ones (excluding those that infringe upon patents).


Growth Factors:


  • Increasing demand for precision medicine
  • Rising prevalence of cancer
  • Growing geriatric population
  • Technological advancements in oncology therapies 5. Increasing healthcare expenditure

Scope Of The Report

Report Attributes

Report Details

Report Title

Peficitinib(CAS 944118-01-8) Market Research Report

By Type

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

By Application

Research, Medical

By Companies

Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals, BOC Sciences, Wuhan Sun-shine Bio-technology, MedKoo Biosciences

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

201

Number of Tables & Figures

141

Customization Available

Yes, the report can be customized as per your need.


Global Peficitinib(CAS 944118-01-8) Market Report Segments:

The global Peficitinib(CAS 944118-01-8) market is segmented on the basis of:

Types

Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Research, Medical

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Cayman Chemical
  2. Adooq Bioscience
  3. BioVision
  4. Biorbyt
  5. MyBiosource
  6. AbMole
  7. Taiclone
  8. Selleck Chemicals
  9. BOC Sciences
  10. Wuhan Sun-shine Bio-technology
  11. MedKoo Biosciences

Global Peficitinib(CAS 944118-01-8) Market Overview


Highlights of The Peficitinib(CAS 944118-01-8) Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Min Purity Less Than 98%
    2. Min Purity 98%-99%
    3. Min Purity More Than 99%
  1. By Application:

    1. Research
    2. Medical
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Peficitinib(CAS 944118-01-8) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Peficitinib(CAS 944118-01-8) Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Peficitinib is a drug that is used to treat cancer. It works by blocking the growth of cancer cells.

Some of the major players in the peficitinib(cas 944118-01-8) market are Cayman Chemical, Adooq Bioscience, BioVision, Biorbyt, MyBiosource, AbMole, Taiclone, Selleck Chemicals, BOC Sciences, Wuhan Sun-shine Bio-technology, MedKoo Biosciences.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Peficitinib(CAS 944118-01-8) Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Peficitinib(CAS 944118-01-8) Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Peficitinib(CAS 944118-01-8) Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Peficitinib(CAS 944118-01-8) Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Peficitinib(CAS 944118-01-8) Market Size & Forecast, 2020-2028       4.5.1 Peficitinib(CAS 944118-01-8) Market Size and Y-o-Y Growth       4.5.2 Peficitinib(CAS 944118-01-8) Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 Min Purity Less Than 98%
      5.2.2 Min Purity 98%-99%
      5.2.3 Min Purity More Than 99%
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Research
      6.2.2 Medical
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Peficitinib(CAS 944118-01-8) Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Peficitinib(CAS 944118-01-8) Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 Min Purity Less Than 98%
      9.6.2 Min Purity 98%-99%
      9.6.3 Min Purity More Than 99%
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Research
      9.10.2 Medical
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 Min Purity Less Than 98%
      10.6.2 Min Purity 98%-99%
      10.6.3 Min Purity More Than 99%
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Research
      10.10.2 Medical
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 Min Purity Less Than 98%
      11.6.2 Min Purity 98%-99%
      11.6.3 Min Purity More Than 99%
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Research
      11.10.2 Medical
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 Min Purity Less Than 98%
      12.6.2 Min Purity 98%-99%
      12.6.3 Min Purity More Than 99%
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Research
      12.10.2 Medical
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 Min Purity Less Than 98%
      13.6.2 Min Purity 98%-99%
      13.6.3 Min Purity More Than 99%
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Research
      13.10.2 Medical
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Peficitinib(CAS 944118-01-8) Market: Competitive Dashboard
   14.2 Global Peficitinib(CAS 944118-01-8) Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Cayman Chemical
      14.3.2 Adooq Bioscience
      14.3.3 BioVision
      14.3.4 Biorbyt
      14.3.5 MyBiosource
      14.3.6 AbMole
      14.3.7 Taiclone
      14.3.8 Selleck Chemicals
      14.3.9 BOC Sciences
      14.3.10 Wuhan Sun-shine Bio-technology
      14.3.11 MedKoo Biosciences

Our Trusted Clients

Contact Us